What microbial limits apply to pharmaceutical gelatin?

Beyond Biopharma | Pharmaceutical Gelatin FAQ

Short answer: Microbial limits for pharmaceutical gelatin are set by the current pharmacopoeia that governs the finished product. Testing typically covers total aerobic microbial count, total combined yeast and mould count, and absence tests for specified objectionable organisms such as Salmonella, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa, using the methods and limits of the applicable monograph edition.

Why an excipient needs microbial control

Gelatin is a protein, and proteins are excellent nutrients for micro-organisms when water is available. Although dried gelatin powder has a low water activity that limits growth, the material can still carry contamination picked up from raw materials or introduced during handling, packaging and storage. For a pharmaceutical excipient the aim is not zero organisms, which is unrealistic for a natural product, but a controlled, low bioburden that will not put the finished dosage form at risk.

What is typically tested

The microbial tests for an excipient normally follow the general microbial chapters of the applicable pharmacopoeia rather than a gelatin-specific test alone. In practice a pharmaceutical gelatin COA will usually show results for the following groups, with limits and methods taken from the current monograph edition:

• Total aerobic microbial count (TAMC) - the overall level of aerobic bacteria and fungi able to grow on the test media.
• Total combined yeast and mould count (TYMC) - a separate check for yeasts and moulds, which matter for hygiene and can indicate storage problems.
• Absence of specified organisms - absence tests for organisms that should never be present, such as Salmonella, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa, with the full list defined by the monograph and the intended use of the material.

How the tests are carried out

Testing is done with the current pharmacopoeial methods for microbial enumeration and for specified micro-organisms. In outline, a representative sample is dissolved or suspended under defined conditions, plated or filtered onto suitable culture media, incubated at defined temperatures, and counted or examined for growth. Results are reported against the limits in the monograph: a numeric count for the enumeration tests and 'absent' or 'not detected' for each specified organism. Because methods differ in detail between pharmacopoeias and change when editions are revised, the method references and edition on the certificate should always be checked.

Why limits are not a fixed universal number

Microbiological acceptance criteria are tied to the pharmacopoeia, the product category and the finished dosage form, and they are revised over time. A number printed on an old datasheet or in a general article from a previous edition may no longer be current, and a limit that fits one market may not match another. This is exactly why the practical rule is to take the limits from the current edition of the pharmacopoeia that governs your product, and to verify the batch results on the supplier certificate of analysis rather than quoting remembered figures.

Practical context for gelatin

Gelatin manufacture itself includes heating steps that kill vegetative organisms, so the main risks in the supply chain are recontamination after processing and growth during poor storage. Buyers therefore look at more than the test results: sealed, intact packaging; clean, dry storage; reasonable shelf-life discipline; and a supplier with a functioning quality system all protect the bioburden status shown on the certificate. Moisture control is part of the same story, because damp conditions are what allow counts to rise between testing and use.

Microbial count versus endotoxin

Microbial limits and endotoxin are often confused but are different controls. Microbial limits describe the level of viable organisms in a material and apply broadly to excipients for oral and other routes. Endotoxin testing measures a heat-stable bacterial component and matters mainly for parenteral, biologic and other sterile applications. Gelatin for ordinary capsules and tablets needs the former; only specialised grades need the latter. See the endotoxin question for when that control applies.

Related reading

See also what purity tests matter for pharmaceutical gelatin, how to read a pharmaceutical gelatin specification (COA) and how pharmacopoeia compliance is tested.